Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2003 03:29 ET | Source: Astex Therapeutics

Astex Announces Drug Discovery Collaboration with the Institute of Cancer Research and Cancer Research Technology

CAMBRIDGE, U.K., March 20, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced an exclusive research collaboration and licence agreement with the...
January 03, 2003 09:43 ET | Source: ViroPharma Incorporated

ViroPharma Announces the Initiation of Phase 1 Hepatitis C Trials and Updates its Product Pipeline and Convertible Notes

EXTON, Pa., Jan. 3, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that, together with Wyeth, it has initiated phase 1 human clinical trials with HCV 371, the lead compound...
December 19, 2002 02:56 ET | Source: Akzo Nobel

Akzo Nobel and Organon Considering Next Moves Following Adverse Summary Judgement Ruling in Remeron Lawsuit Against Generics

ARNHEM, The Netherlands and WEST ORANGE, N.J., Dec. 19, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) and Organon Inc. confirm that the U.S. Federal District Court in Newark, NJ, has granted summary...
December 13, 2002 08:25 ET | Source: Medivir

Medivir and Paradigm Enter Alliance

HUDDINGE, Sweden, Dec. 13, 2002 (PRIMEZONE) -- Medivir and Paradigm Therapeutics Ltd (Cambridge, U.K.) have entered a broad-based, 3-year research collaboration to identify novel protease drug...
April 12, 2002 05:07 ET | Source: Pharmexa A/S

Pharmexa Announces that GlaxoSmithKline has Exclusive Option on HER-2 Protein Breast Cancer Project

HORSHOLM, Denmark, April 12, 2002 (PRIMEZONE) -- In June 2001 Pharmexa announced that it had in-licensed a vector-cell production system from GlaxoSmithKline (NYSE:GSK) for use in Pharmexa's...